News Archive - Stand Up To Cancer

News

LATEST UPDATES

READ MORE

Know Your Risk: 10 Things Blacks Need to Know About Colorectal Cancer

Colorectal cancer remains a significant health concern, particularly for the Black community, which faces higher incidence rates and lower survival rates compared to the white population.

Read More
READ MORE

‘Advocate for yourself’: Cancer survivor shares importance of screenings during Colorectal Cancer Awareness Month

When Sascha Roth of Northwest D.C. noticed bleeding as she went to the bathroom, she initially shrugged it off. She would later be diagnosed with Stage 3 rectal cancer.

Read More
READ MORE

Addressing Underrepresentation In Cancer Trials: A Q&A With Stand Up To Cancer & Triage Cancer

A conversation with Stand Up To Cancer researcher Chanita Hughes-Halbert, Ph.D., and grant recipient Triage Cancer co-founder and COO Monica Fawzy Bryant, Esq.

Read More
READ MORE

“Here’s How I Knew I Had Colon Cancer”: One Survivor’s Story After a Single, Subtle Symptom

Colon cancer symptoms often don’t exist. An active woman shares how repeated nudges from a loved one led to her diagnosis: “My entire life changed that day.”

Read More
READ MORE

Stand Up to Cancer announces changes to scientific advisory committee

Stand Up To Cancer® announced changes to its Scientific Advisory Committee (SAC), which oversees SU2C’s scientific research.

Read More
READ MORE

Healthcare Moves: A Monthly Summary of Hires and Layoffs

Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.

Read More
READ MORE

MarketingRx roundup: AbbVie, Sanofi and Regeneron lead pharma ad spend; BMS launches new equity grants

AbbVie is leading branded drug ad spending this year with Skyrizi at $415 million through the first nine months of the year, according to Vivvix data. Sanofi and Regeneron’s Dupixent is in second at $369 million, but another AbbVie brand, Rinvoq, is a close third with $357 million spent so far, according to the MediaRadar company, with paid social data from Pathmatics.

 

Read More
READ MORE

Stand Up to Cancer names Julian Adams, Ph.D., President and CEO

Stand Up To Cancer® (SU2C) today announced the appointment of Julian Adams, Ph.D., as president and chief executive officer, which will be effective on January 1, 2024. Adams had previously served on SU2C’s Scientific Advisory Committee since 2008, and officially joined SU2C in July 2023 in the newly created position of chief science officer.

Read More
READ MORE

Stand Up To Cancer unveils new gastroesophageal cancer research teams and awards

Stand Up To Cancer® (SU2C) today announced three Research Teams focused on bringing new therapies to clinical trials for the treatment of gastroesophageal cancer (GEC). The Research Teams, a part of a Dream Team Collective supported by the Torrey Coast Foundation, will unite top researchers from 11 institutions to address critical problems in GEC prevention, diagnosis and treatment.

Read More
READ MORE

SU2C recognized by CHOP and SITC for support of cancer research

Stand Up To Cancer was recognized by Children’s Hospital of Philadelphia and the Society for Immunotherapy of Cancer for the contributions and achievements SU2C has made in raising funds and awareness to help cancer research.

Read More

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.